Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates

Bioconjugate Chemistry

Volumn 21, Issue 9, 2010, Pages 1662-1672

  Eiríksdóttir, Emelía ^a   Mäger, Imre ^a,b   Lehto, Taavi ^b   El Andaloussi, Samir ^a,b,c   Langel, Ülo ^a,b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITY OF TARTU   (Estonia)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CELL PENETRATING PEPTIDE; LACTATE DEHYDROGENASE; LUCIFERIN; MICROTUBULE ASSOCIATED PROTEIN; PENETRATIN; PROTEIN M918; PROTEIN PVEC; UNCLASSIFIED DRUG;

ARTICLE; CELL KINETICS; CHEMICAL STRUCTURE; ENDOCYTOSIS; INTERNALIZATION; MEMBRANE PERMEABILITY; SYNTHESIS;

EID: 77956641791     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc100174y     Document Type: Article

References (73)

1. Derossi, D., Joliot, A. H., Chassaing, G., and Prochiantz, A. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes J. Biol. Chem. 269, 10444-50
2. Vivés, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus J. Biol. Chem. 272, 16010-7
3. Elliott, G. and O'Hare, P. (1997) Intercellular trafficking and protein delivery by a herpesvirus structural protein Cell 88, 223-33
4. Pooga, M., Hällbrink, M., Zorko, M., and Langel, Ü. (1998) Cell penetration by transportan FASEB J. 12, 67-77
5. Lee, H. S., Park, C. B., Kim, J. M., Jang, S. A., Park, I. Y., Kim, M. S., Cho, J. H., and Kim, S. C. (2008) Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide Cancer Lett. 271, 47-55
6. Park, C. B., Yi, K. S., Matsuzaki, K., Kim, M. S., and Kim, S. C. (2000) Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II Proc. Natl. Acad. Sci. U.S.A. 97, 8245-50
7. Zania, P., Gourni, D., Aplin, A. C., Nicosia, R. F., Flordellis, C. S., Maragoudakis, M. E., and Tsopanoglou, N. E. (2009) Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis J. Pharmacol. Exp. Therapeut. 328, 378-389
8. Crombez, L., Aldrian-Herrada, G., Konate, K., Nguyen, Q. N., McMaster, G. K., Brasseur, R., Heitz, F., and Divita, G. (2009) A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells Mol. Ther. 17, 95-103
9. Ivanova, G. D., Arzumanov, A., Abes, R., Yin, H., Wood, M. J. A., Lebleu, B., and Gait, M. J. (2008) Improved cell-penetrating peptide - PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle Nucleic Acids Res. 36, 6418-6428
10. Morris, M. C., Depollier, J., Mery, J., Heitz, F., and Divita, G. (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells Nat. Biotechnol. 19, 1173-1176
11. Futaki, S., Ohashi, W., Suzuki, T., Niwa, M., Tanaka, S., Ueda, K., Harashima, H., and Sugiura, Y. (2001) Stearylated arginine-rich peptides: A new class of transfection systems Bioconjugate Chem. 12, 1005-1011
12. Mäe, M., El Andaloussi, S., Lundin, P., Oskolkov, N., Johansson, H. J., Guterstam, P., and Langel, Ü. (2009) A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy J. Controlled Release 134, 221-227
13. Nakamura, Y., Kogure, K., Futaki, S., and Harashima, H. (2007) Octaarginine-modified multifunctional envelope-type nano device for siRNA J. Controlled Release 119, 360-367
14. Rothbard, J. B., Kreider, E., Vandeusen, C. L., Wright, L., Wylie, B. L., and Wender, P. A. (2002) Arginine-rich molecular transporters for drug delivery: Role of backbone spacing in cellular uptake J. Med. Chem. 45, 3612-3618
15. Simeoni, F., Morris, M. C., Heitz, F., and Divita, G. (2003) Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells Nucleic Acids Res. 31, 2717-2724
16. Tonges, L., Lingor, P., Egle, R., Dietz, G. P. H., Fahr, A., and Bahr, M. (2006) Stearylated octaarginine and artificial virus-like particles for transfection of siRNA into primary rat neurons RNA 12, 1431-1438
17. Abes, R., Arzumanov, A., Moulton, H., Abes, S., Ivanova, G., Gait, M. J., Iversen, P., and Lebleu, B. (2008) Arginine-rich cell penetrating peptides: Design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides J. Pept. Sci. 14, 455-460
18. Chen, B., Liu, Q. L., Zhang, Y. L., Xu, L., and Fang, X. H. (2008) Transmembrane delivery of the cell-penetrating peptide conjugated semiconductor quantum dots Langmuir 24, 11866-11871
19. Järver, P., Langel, K., El Andaloussi, S., and Langel, Ü. (2007) Applications of cell-penetrating peptides in regulation of gene expression Biochem. Soc. Trans. 35, 770-774
20. Kersemans, V., Kersemans, K., and Cornelissen, B. (2008) Cell penetrating peptides for in vivo molecular imaging applications Curr. Pharm. Des. 14, 2415-2427
21. Lundin, P., Johansson, H., Guterstam, P., Holm, T., Hansen, M., Langel, U., and El Andaloussi, S. (2008) Distinct uptake routes of cell-penetrating peptide conjugates Bioconjugate Chem. 19, 2535-42
22. Kang, S. H., Cho, M. J., and Kole, R. (1998) Up-regulation of luciferase gene expression with antisense oligonucleotides: Implications and applications in functional assay developments Biochemistry 37, 6235-6239
23. Jones, L. R., Goun, E. A., Shinde, R., Rothbard, J. B., Contag, C. H., and Wender, P. A. (2006) Releasable luciferin-transporter conjugates: tools for the real-time analysis of cellular uptake and release J. Am. Chem. Soc. 128, 6526-7
24. Seliger, H. H. and Mc, E. W. (1960) Spectral emission and quantum yield of firefly bioluminescence Arch. Biochem. Biophys. 88, 136-41
25. Wender, P. A., Goun, E. A., Jones, L. R., Pillow, T. H., Rothbard, J. B., Shinde, R., and Contag, C. H. (2007) Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice Proc. Natl. Acad. Sci. U.S.A. 104, 10340-5
26. Mäger, I., Eiríksdóttir, E., Langel, K., El Andaloussi, S., and Langel, Ü. (2010) Assessing the uptake kinetics and internalization mechanisms of cell-penetrating peptides using a quenched fluorescence assay. Biochim. Biophys. Acta 1798, 338 - 343.
27. Lundberg, P., El Andaloussi, S., Sütlü, T., Johansson, H., and Langel, Ü. (2007) Delivery of short interfering RNA using endosomolytic cell-penetrating peptides FASEB J. 21, 2664-2671
28. El Andaloussi, S., Johansson, H. J., Holm, T., and Langel, Ü. (2007) A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids Mol. Ther. 15, 1820-1826
29. Elmquist, A., Lindgren, M., Bartfai, T., and Langel, Ü. (2001) VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions Exp. Cell Res. 269, 237-244
30. Soomets, U., Lindgren, M., Gallet, X., Hällbrink, M., Elmquist, A., Balaspiri, L., Zorko, M., Pooga, M., Brasseur, R., and Langel, Ü. (2000) Deletion analogues of transportan Biochim. Biophys. Acta 1467, 165-176
31. Oehlke, J., Scheller, A., Wiesner, B., Krause, E., Beyermann, M., Klauschenz, E., Melzig, M., and Bienert, M. (1998) Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically Biochim. Biophys. Acta 1414, 127-139
32. Eiríksdóttir, E., Langel, Ü., and Rosenthal-Aizman, K. (2009) An improved synthesis of releasable luciferin-CPP conjugates Tetrahedron Lett. 50, 4731-4733
33. Moate, P. J., Dougherty, L., Schnall, M. D., Landis, R. J., and Boston, R. C. (2004) A modified logistic model to describe gadolinium kinetics in breast tumors Magn. Reson. Imaging 22, 467-473
34. El Andaloussi, S., Järver, P., Johansson, H. J., and Langel, Ü. (2007) Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study Biochem. J. 407, 285-292
35. Saar, K., Lindgren, M., Hansen, M., Eiríksdóttir, E., Jiang, Y., Rosenthal-Aizman, K., Sassian, M., and Langel, Ü. (2005) Cell-penetrating peptides: a comparative membrane toxicity study Anal. Biochem. 345, 55-65
36. Myrberg, H., Lindgren, M., and Langel, Ü. (2007) Protein delivery by the cell-penetrating peptide YTA2 Bioconjugate Chem. 18, 170-174
37. Palm, C., Jayamanne, M., Kjellander, M., and Hällbrink, M. (2007) Peptide degradation is a critical determinant for cell-penetrating peptide uptake Biochim. Biophys. Acta 1768, 1769-1776
38. Henriques, S. T., Melo, M. N., and Castanho, M. (2007) How to address CPP and AMP translocation? Methods to detect and quantify peptide internalization in vitro and in vivo (Review) Mol. Membr. Biol. 24, U3-U2
39. Craig, F. F., Simmonds, A. C., Watmore, D., McCapra, F., and White, M. R. (1991) Membrane-permeable luciferin esters for assay of firefly luciferase in live intact cells Biochem. J. 276 (Pt 3) 637-41
40. Ter-Avetisyan, G., Tunnemann, G., Nowak, D., Nitschke, M., Herrmann, A., Drab, M., and Cardoso, M. C. (2009) Cell entry of arginine-rich peptides is independent of endocytosis J. Biol. Chem. 284, 3370-8
41. Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R., and Brock, R. (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides Traffic 8, 848-866
42. Futaki, S., Nakase, I., Tadokoro, A., Takeuchi, T., and Jones, A. T. (2007) Arginine-rich peptides and their internalization mechanisms Biochem. Soc. Trans. 35, 784-7
43. Richard, J. P., Melikov, K., Brooks, H., Prevot, P., Lebleu, B., and Chernomordik, L. V. (2005) Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors J. Biol. Chem. 280, 15300-6
44. Wadia, J. S., Stan, R. V., and Dowdy, S. F. (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis Nat. Med. 10, 310-5
45. Hällbrink, M., Florén, A., Elmquist, A., Pooga, M., Bartfai, T., and Langel, Ü. (2001) Cargo delivery kinetics of cell-penetrating peptides Biochim. Biophys. Acta 1515, 101-109
46. Barany-Wallje, E., Gaur, J., Lundberg, P., Langel, Ü., and Gräslund, A. (2007) Differential membrane perturbation caused by the cell penetrating peptide Tp10 depending on attached cargo FEBS Lett. 581, 2389-93
47. Fretz, M. M., Penning, N. A., Al-Taei, S., Futaki, S., Takeuchi, T., Nakase, I., Storm, G., and Jones, A. T. (2007) Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34(+) leukaemia cells Biochem. J. 403, 335-342
48. Zaro, J. L., Vekich, J. E., Tran, T., and Shen, W. C. (2009) Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells. Mol. Pharm.
49. Palm-Apergi, C., Lorents, A., Padari, K., Pooga, M., and Hällbrink, M. (2009) The membrane repair response masks membrane disturbances caused by cell-penetrating peptide uptake FASEB J. 23, 214-23
50. Barany-Wallje, E., Keller, S., Serowy, S., Geibel, S., Pohl, P., Bienert, M., and Dathe, M. (2005) A critical reassessment of penetratin translocation across lipid membranes Biophys. J. 89, 2513-2521
51. Ribeiro, C. and Esteves da Silva, J. C. (2008) Kinetics of inhibition of firefly luciferase by oxyluciferin and dehydroluciferyl-adenylate Photochem. Photobiol. Sci. 7, 1085-90
52. Cheung, J. C., Kim Chiaw, P., Deber, C. M., and Bear, C. E. (2009) A novel method for monitoring the cytosolic delivery of peptide cargo. J. Controlled Release 137, 2 - 7.
53. Barnes, M. P. and Shen, W. C. (2009) Disulfide and thioether linked cytochrome c-oligoarginine conjugates in HeLa cells Int. J. Pharm. 369, 79-84
54. El Andaloussi, S., Guterstam, P., and Langel, Ü. (2007) Assessing the delivery efficacy and internalization route of cell-penetrating peptides Nat. Protoc. 2, 2043-7
55. Patel, L. N., Wang, J., Kim, K. J., Borok, Z., Crandall, E. D., and Shen, W. C. (2009) Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin Mol. Pharm. 6, 492-503
56. Turner, J. J., Jones, S., Fabani, M. M., Ivanova, G., Arzumanov, A. A., and Gait, M. J. (2007) RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA Blood Cells Mol. Dis. 38, 1-7
57. Saito, G., Swanson, J. A., and Lee, K. D. (2003) Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities Adv. Drug Delivery Rev. 55, 199-215
58. Shen, W. C., Ryser, H. J., and LaManna, L. (1985) Disulfide spacer between methotrexate and poly(D-lysine). A probe for exploring the reductive process in endocytosis J. Biol. Chem. 260, 10905-8
59. Aubry, S., Burlina, F., Dupont, E., Delaroche, D., Joliot, A., Lavielle, S., Chassaing, G., and Sagan, S. (2009) Cell-surface thiols affect cell entry of disulfide-conjugated peptides FASEB J. 23, 2956-2967
60. Adessi, C. and Soto, C. (2002) Converting a peptide into a drug: Strategies to improve stability and bioavailability Curr. Med. Chem. 9, 963-978
61. El Andaloussi, S., Johansson, H. J., Lundberg, P., and Langel, Ü. (2006) Induction of splice correction by cell-penetrating peptide nucleic acids J. Gene Med. 8, 1262-1273
62. Kosuge, M., Takeuchi, T., Nakase, I., Jones, A. T., and Futaki, S. (2008) Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans Bioconjugate Chem. 19, 656-664
63. Lindgren, M., Gallet, X., Soomets, U., Hällbrink, M., Bråkenhielm, E., Pooga, M., Brasseur, R., and Langel, Ü. (2000) Translocation properties of novel cell penetrating transportan and penetratin analogues Bioconjugate Chem. 11, 619-26
64. Drin, G., Cottin, S., Blanc, E., Rees, A. R., and Temsamani, J. (2003) Studies on the internalization mechanism of cationic cell-penetrating peptides J. Biol. Chem. 278, 31192-201
65. Letoha, T., Gaal, S., Somlai, C., Czajlik, A., Perczel, A., and Penke, B. (2003) Membrane translocation of penetratin and its derivatives in different cell lines J. Mol. Recognit. 16, 272-9
66. Jiao, C. Y., Delaroche, D., Burlina, F., Alves, I. D., Chassaing, G., and Sagan, S. (2009) Translocation and endocytosis for cell-penetrating peptide internalization J. Biol. Chem. 284, 33957-65
67. Jones, S. W., Christison, R., Bundell, K., Voyce, C. J., Brockbank, S. M., Newham, P., and Lindsay, M. A. (2005) Characterisation of cell-penetrating peptide-mediated peptide delivery Br. J. Pharmacol. 145, 1093-102
68. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., and Lebleu, B. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake J. Biol. Chem. 278, 585-90
69. Suzuki, T., Futaki, S., Niwa, M., Tanaka, S., Ueda, K., and Sugiura, Y. (2002) Possible existence of common internalization mechanisms among arginine-rich peptides J. Biol. Chem. 277, 2437-43
70. Ignatovich, I. A., Dizhe, E. B., Pavlotskaya, A. V., Akifiev, B. N., Burov, S. V., Orlov, S. V., and Perevozchikov, A. P. (2003) Complexes of plasmid DNA with basic domain 47 - 57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways J. Biol. Chem. 278, 42625-36
71. Takayama, K., Nakase, I., Michiue, H., Takeuchi, T., Tomizawa, K., Matsui, H., and Futaki, S. (2009) Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas) J. Controlled Release 138, 128-33
72. Eiríksdóttir, E., Konate, K., Langel, Ü., Divita, G., and Deshayes, S. Secondary structure of cell-penetrating peptides controls membrane interaction and insertion. Biochim. Biophys. Acta 1798, 1119 - 1128.
73. Hennig, L. (1999) WinGene/WinPep: User-friendly software for the analysis of amino acid sequences Biotechniques 26, 1170-1172